UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 10, 2018 4:00 P.M.
Form:
S-1
CIK:
0001737287
Company Name:
Allogene Therapeutics, Inc.
File Number:
333-227333